相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study
Carme Loras et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Use of Infliximab in Particular Clinical Settings: Management Based on Current Evidence
Alfredo Papa et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Spondyloarthropathy and chronic B hepatitis. Effect of anti-TNF therapy
Daniel Wendling et al.
JOINT BONE SPINE (2009)
Use of Tumor Necrosis Factor-alpha-blocking Agents in Hepatitis B Virus-positive Patients: Reports of 3 Cases and Review of the Literature
Stefania Zingarelli et al.
JOURNAL OF RHEUMATOLOGY (2009)
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression
L. Peyrin-Biroulet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Association of MTRR 66A>G polymorphism with superoxide dismutase and disease activity in patients with Crohn's disease
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab
Keisuke Ojiro et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Giovanni Raimondo et al.
JOURNAL OF HEPATOLOGY (2008)
Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro
Feng Yang et al.
JOURNAL OF VIROLOGY (2008)
Fulminant hepatic failure in chronic hepatitis B on withdrawal of corti costeroids, azathioprine and infliximab for Crohn's disease
Carmelita Colbert et al.
INFLAMMATORY BOWEL DISEASES (2007)
Occult hepatitis B and infliximab-induced HBV reactivation
Salvatore Madonia et al.
INFLAMMATORY BOWEL DISEASES (2007)
Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses
Gil Y. Melmed et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Onset of inflammatory bowel diseases during combined α-interferon and ribavirin therapy for chronic hepatitis C:: report of two cases
F Villa et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study
NN Zein
JOURNAL OF HEPATOLOGY (2005)
Evolution of strategy and coverage rates for hepatitis B vaccination in France, a country with low endemicity
F Denis et al.
MEDECINE ET MALADIES INFECTIEUSES (2004)
Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients:: need for primary prophylaxis
M Esteve et al.
GUT (2004)
The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates
A Jafarzadeh et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis
H Tilg et al.
GUT (2003)
Hepatitis B and C virus infection in Crohn's disease
L Biancone et al.
INFLAMMATORY BOWEL DISEASES (2001)
分享论文
